Search research articles
Contact Us
Filters
Showing results (131-140 of 145) with videos related to
Page
of 15
Sort By:
Cancer Immunology, Immunotherapy : CII
|
August 31, 2022
Divergent clinical outcomes in a phase 2B trial of the TLPLDC vaccine in preventing melanoma recurrence and the impact of dendritic cell collection methodology: a randomized clinical trial
Alexandra M Adams, Elizabeth L Carpenter, Guy T Clifton, et al.
Annals of Surgical Oncology
|
October 14, 2025
International Survey on Evidence for Index Lymph Node Surgery After Neoadjuvant Systemic Therapy for Stage III Melanoma
Elan Novis, Mervi Rautalin, Rodabe N Amaria, et al.
Annals of Surgical Oncology
|
February 23, 2017
The Impact of Smoking on Sentinel Node Metastasis of Primary Cutaneous Melanoma
Maris S Jones, Peter C Jones, Stacey L Stern, et al.
Annals of Surgical Oncology
|
January 23, 2026
ASO Visual Abstract: International Survey on Evidence for Index Lymph Node Surgery Following Neoadjuvant Systemic Therapy for Stage III Melanoma
Elan Novis, Mervi Rautalin, Rodabe N Amaria, et al.
Annals of Surgical Oncology
|
May 2, 2022
Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in the Second Multicenter Selective Lymphadenectomy Trial (MSLT-II)
James W Jakub, Michael Lowe, J Harrison Howard, et al.
Cancer Treatment and Research Communications
|
September 21, 2024
Tumor lysate particle only vaccine (TLPO) vs. Tumor lysate particle-loaded, dendritic cell vaccine (TLPLDC) to prevent recurrence in resected stage III/IV melanoma patients: Results of a phase I/IIa trial
Spencer G Van Decar, Elizabeth L Carpenter, Alexandra M Adams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 2, 2020
Systemic Therapy for Melanoma: ASCO Guideline
Rahul Seth, Hans Messersmith, Varinder Kaur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 14, 2023
Systemic Therapy for Melanoma: ASCO Guideline Update
Rahul Seth, Sanjiv S Agarwala, Hans Messersmith, et al.
Annals of Surgery
|
June 13, 2019
Preoperative Ultrasound Assessment of Regional Lymph Nodes in Melanoma Patients Does not Provide Reliable Nodal Staging: Results From a Large Multicenter Trial
John F Thompson, Lauren E Haydu, Roger F Uren, et al.
Annals of Surgical Oncology
|
April 15, 2022
Correction to: Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)
Alexander C J van Akkooi, Tina J Hieken, Elizabeth M Burton, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 145) with videos related to
Sort By:
Page
of 15
Cancer Immunology, Immunotherapy : CII
|
August 31, 2022
Divergent clinical outcomes in a phase 2B trial of the TLPLDC vaccine in preventing melanoma recurrence and the impact of dendritic cell collection methodology: a randomized clinical trial
Alexandra M Adams, Elizabeth L Carpenter, Guy T Clifton, et al.
Annals of Surgical Oncology
|
October 14, 2025
International Survey on Evidence for Index Lymph Node Surgery After Neoadjuvant Systemic Therapy for Stage III Melanoma
Elan Novis, Mervi Rautalin, Rodabe N Amaria, et al.
Annals of Surgical Oncology
|
February 23, 2017
The Impact of Smoking on Sentinel Node Metastasis of Primary Cutaneous Melanoma
Maris S Jones, Peter C Jones, Stacey L Stern, et al.
Annals of Surgical Oncology
|
January 23, 2026
ASO Visual Abstract: International Survey on Evidence for Index Lymph Node Surgery Following Neoadjuvant Systemic Therapy for Stage III Melanoma
Elan Novis, Mervi Rautalin, Rodabe N Amaria, et al.
Annals of Surgical Oncology
|
May 2, 2022
Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in the Second Multicenter Selective Lymphadenectomy Trial (MSLT-II)
James W Jakub, Michael Lowe, J Harrison Howard, et al.
Cancer Treatment and Research Communications
|
September 21, 2024
Tumor lysate particle only vaccine (TLPO) vs. Tumor lysate particle-loaded, dendritic cell vaccine (TLPLDC) to prevent recurrence in resected stage III/IV melanoma patients: Results of a phase I/IIa trial
Spencer G Van Decar, Elizabeth L Carpenter, Alexandra M Adams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 2, 2020
Systemic Therapy for Melanoma: ASCO Guideline
Rahul Seth, Hans Messersmith, Varinder Kaur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 14, 2023
Systemic Therapy for Melanoma: ASCO Guideline Update
Rahul Seth, Sanjiv S Agarwala, Hans Messersmith, et al.
Annals of Surgery
|
June 13, 2019
Preoperative Ultrasound Assessment of Regional Lymph Nodes in Melanoma Patients Does not Provide Reliable Nodal Staging: Results From a Large Multicenter Trial
John F Thompson, Lauren E Haydu, Roger F Uren, et al.
Annals of Surgical Oncology
|
April 15, 2022
Correction to: Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)
Alexander C J van Akkooi, Tina J Hieken, Elizabeth M Burton, et al.
Page
of 15